<SEC-DOCUMENT>0000950170-21-001903.txt : 20210927
<SEC-HEADER>0000950170-21-001903.hdr.sgml : 20210927
<ACCEPTANCE-DATETIME>20210927160558
ACCESSION NUMBER:		0000950170-21-001903
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210927
ITEM INFORMATION:		Cost Associated with Exit or Disposal Activities
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210927
DATE AS OF CHANGE:		20210927

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ZIOPHARM ONCOLOGY INC
		CENTRAL INDEX KEY:			0001107421
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841475642
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33038
		FILM NUMBER:		211281712

	BUSINESS ADDRESS:	
		STREET 1:		ONE FIRST AVENUE
		STREET 2:		PARRIS BUILDING 34, NAVY YARD PLAZA
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02129
		BUSINESS PHONE:		617-259-1970

	MAIL ADDRESS:	
		STREET 1:		ONE FIRST AVENUE
		STREET 2:		PARRIS BUILDING 34, NAVY YARD PLAZA
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02129

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EASYWEB INC
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ziop-20210927.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-27T16:03:40.0154+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ziop="http://ziopharm.com/20210927">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_3b3dccd8-1d5f-4e09-8ebf-408b0d0293d0" name="dei:EntityCentralIndexKey" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c">0001107421</ix:nonNumeric><ix:nonNumeric id="F_e55c8d0b-b596-4119-87e8-7710132cfec3" name="dei:AmendmentFlag" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ziop-20210927.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-27</xbrli:startDate><xbrli:endDate>2021-09-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.250pt double rgba(0,0,0,1);text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.75pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.2pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5c9b9364-31ec-4c74-8795-14da4f1a9395" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.2pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">CURRENT REPORT</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Date of Report (Date of earliest event reported): </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eab4f9c9-36ca-4d85-a75d-5ecf50f8918c" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">September 27, 2021</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:24.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e254f89-ca0b-4a3a-9a23-82e6f62c3dda" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityRegistrantName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:24.0pt;font-family:Times New Roman;">ZIOPHARM Oncology, Inc.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:20.0%;"></td>
    <td style="width:18.0%;"></td>
    <td style="width:41.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_770ad491-71ef-425c-900b-5315837a1f8b" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0127a9b9-1da4-4edd-8e44-dcc013485407" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">001-33038</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6c9baaf2-e098-402d-86aa-da28a07880bb" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">84-1475642</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Commission File Number)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3ea4f041-be69-489f-aaa8-dd2b124ed89b" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">One First Avenue</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d53c62f6-4de4-4c95-9089-de8a29362cda" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Parris Building 34, Navy Yard Plaza</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4486a0fa-6807-4acc-9f46-485e00ddfada" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Boston</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6c856e64-39e9-42e5-a43b-94278055e3de" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_100dd3fa-f8d9-4bc5-9f67-a8302ca9185c" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">02129</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td colspan="3" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Address of Principal Executive Offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;margin-right:0.02986111111111111in;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b65df2e-d69d-455e-ad89-c09d09b8e57c" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:CityAreaCode"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">617</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_68a1776e-f2e7-4677-8ad6-b4ea5eb20168" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:LocalPhoneNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">259-1970</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.125in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_eb96a137-83d6-471a-9966-4c69f84566d7" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityInformationFormerLegalOrRegisteredName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Not Applicable</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;line-height:0.05pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid rgba(0,0,0,1);margin-right:40.0%;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.35pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9.0pt;line-height:1.3;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a1636ccd-df32-4715-a8ca-74472a75aa35" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;line-height:1.3;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9fc6b5fd-374b-4ee8-88ec-5a229b8c01ef" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;line-height:1.3;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e7e18c2b-7958-44af-8efd-bd423c472a77" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6.0pt;line-height:1.3;margin-bottom:0.0pt;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_087f7cb2-9d8a-436b-b2e5-4ad31bdb5d40" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:9.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:15.0%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:45.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.250pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"><br />Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.250pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Trading<br />Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.250pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e5d88138-610d-40cf-8e9e-88f12dd841eb" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:Security12bTitle"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Common Stock, par value $0.001 per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_927e0269-7523-4c97-a554-fc39b00f8b05" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ZIOP</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bd214ee7-92f0-4eaa-8baf-1c51fb07a24c" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NASDAQ Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Emerging growth company </span><span style="font-size:10.0pt;"><ix:nonNumeric id="F_0d1d83d7-19b9-4b92-b340-cf641fefe283" contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:9.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:0.1pt;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double rgba(0,0,0,1);text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2.05 Costs Associated with Exit or Disposal Activities.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 27, 2021, Ziopharm Oncology, Inc. (the &#x201c;Company&#x201d;) </span><span style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> announced a restructuring enabling the company to advance its TCR program. Approximately 60 positions have been eliminated, representing more than 50% of its workforce. The Company expects the changes will extend its cash runway into the first half of 2023. The Company estimates that it will incur total expenses relating to the restructuring of approximately $3.8 million for severance and termination-related costs. All the severance and termination-related costs represent cash expenditures. The Company expects to record these charges in the third quarter of 2021. The Company also announced the first patient in its TCR-T Library Phase I/II clinical trial is expected to be dosed in the first half of 2022, after experiencing unforeseen delays caused by its contract manufacturer. A copy of the press release announcing the restructuring and this estimated dosing schedule is attached as Exhibit 99 to this Current Report on form 8-K and is incorporated by reference to this item.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Forward-Looking Statements</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The disclosure contained in this Current Report on Form 8-K contains certain forward-looking information about the Company that is intended to be covered by the safe harbor for &#x201c;forward-looking statements&#x201d; provided by the Private Securities Litigation Reform Act of 1995, as amended. Forward looking statements are statements that are not historical facts. Words such as &#x201c;expect(s),&#x201d; &#x201c;feel(s),&#x201d; &#x201c;believe(s),&#x201d; &#x201c;will,&#x201d; &#x201c;may,&#x201d; &#x201c;anticipate(s)&#x201d; and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the benefits of the proposed restructuring program, the anticipated timing and details of the reduction in force, expected charges and costs associated with the reduction in workforce that the Company expects to incur in the second quarter of 2021. These statements are based on current expectations, estimates and projections about the Company&#x2019;s business based, in part, on assumptions made by management, and are subject to a number of risks and uncertainties. Factors that could cause actual results to differ materially from current expectations include possible changes in the expected costs and</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">charges associated with the reduction in force, and risks associated with the Company&#x2019;s ability to achieve the expected benefits of the reduction in force and realignment of its resources. Additionally, these forward-looking statements should be considered in conjunction with the cautionary statements and risk factors described in the Company&#x2019;s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, as amended, and its other filings with the SEC.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7.01 Regulation FD Disclosure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On September 27, 2021, the Company issued a press release announcing the events set forth in Item 2.05. A copy of the press release is attached hereto as Exhibit 99.1.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9.01 Financial Statements and Exhibits.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (d) 	Exhibits<br /><br /><br />				<br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit<br /><br />No.			Description</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><br /><br />				<br /><br />99.1 		</span><a href="ziop-20210927ex99_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Press Release of ZIOPHARM Oncology, Inc. dated September 27, 2021.</span></a><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104  		Cover Page Interactive Data File (embedded within the Inline XBRL document).</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;"><br /><br />				<br /><br /><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:9.35pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNATURES</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:6.0%;"></td>
    <td style="width:44.0%;"></td>
    <td style="width:4.0%;"></td>
    <td style="width:46.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;line-height:1.3;font-family:Times New Roman;margin-bottom:4.3pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ZIOPHARM ONCOLOGY, INC.</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">September 27, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;border-bottom:0.250pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:4.3pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Timothy Cunningham</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.7pt;line-height:1.3;font-family:Times New Roman;margin-bottom:9.35pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Name: Timothy Cunningham<br />Title: Interim Chief Financial Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ziop-20210927ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 99.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img55878624_0.jpg" alt="img55878624_0.jpg" style="width:202px;height:99px;">&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Arial;">Ziopharm Oncology Announces Strategic Reduction in Workforce and Extension in Cash Runway</font></p>
  <div style="display:flex;margin-top:18.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Arial;font-style:italic;">Over 50% reduction in personnel</font></div></div>
  <div style="display:flex;margin-top:3.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Arial;font-style:italic;">Cost reductions expected to extend the cash runway into the first half of 2023</font></div></div>
  <div style="display:flex;margin-top:3.0pt;line-height:1.3;justify-content:center;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Symbol;display:inline-block;font-size:11.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:Arial;font-style:italic;">The first patient in its TCR-T Library Phase I/II clinical trial is expected to be dosed in 1H2022</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">BOSTON and HOUSTON, September 27, 2021</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> -- </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Arial;">Ziopharm Oncology</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">, Inc. (&#x201c;Ziopharm&#x201d; or the &#x201c;Company&#x201d;) (Nasdaq: ZIOP), </font><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">today announced a restructuring enabling the company to advance its TCR program. Approximately 60 positions have been eliminated. The Company expects the changes will extend the cash runway into the first half of 2023.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Kevin S. Boyle, Sr., Chief Executive Officer, said, &#x201c;We appreciate the many contributions the impacted employees made to Ziopharm and we commit to supporting these valued colleagues during this transition. We believe today&#x2019;s strategic decision was necessary to create an organization structured and staffed for success and focused on the goal of generating clinical data in our promising TCR-T Library program. I am confident in the ability of our highly talented team to execute our strategy.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">&#x201c;The Board is fully supportive of Kevin and this capital allocation strategy and creating focus at Ziopharm,&#x201d; said James Huang, Executive Chairman of the Board. &#x201c;Ziopharm is singularly concentrated on being a leading TCR-T company and with this action today Kevin has demonstrated the strategic vision and leadership skills needed for our future.&#x201d;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The Company also announced the first patient in its TCR-T Library Phase I/II clinical trial is expected to be dosed in the first half of 2022 after experiencing unforeseen delays caused by inadequate resources at its contract manufacturer. The Company is continuing to invest in its own manufacturing capabilities to accelerate patient dosing and is committed to having internal manufacturing capabilities operational in the first half of 2022 to support the first patient dosing.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">The Company is focused on executing on the following key strategic goals:</font></p>
  <div style="margin-left:10.0%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Creating a robust Research &amp; Development organization capable of generating IP for new TCRs targeting hotspot mutations</font></div></div>
  <div style="margin-left:10.0%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Operationalizing internal manufacturing capable of supporting early-stage trials</font></div></div>
  <div style="margin-left:10.0%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Generating clinical data </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">in our TCR-T investigational trial</font></div></div>
  <div style="margin-left:10.0%;display:flex;margin-top:0.0pt;line-height:1.3;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:0.25in;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Symbol;display:inline-block;font-size:10.0pt;font-family:Symbol;justify-content:flex-start;min-width:0.25in;">&#xf0b7;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Continuing transparent communication with our shareholders and serving as </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">responsible stewards of capital</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">About Ziopharm Oncology, Inc.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Ziopharm is a clinical-stage oncology-focused cell therapy company, developing T-cell receptor (TCR) therapies based on its non-viral </font><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;font-style:italic;">Sleeping Beauty</font><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;"> gene transfer platform and its unique cancer hotspot Library, covering common tumor-related mutations in key oncolytic genes such as KRAS and TP53. The Company has clinical and strategic collaborations with the National Cancer Institute and The University of Texas MD Anderson Cancer Center. For more information, please visit </font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Arial;">www.ziopharm.com</font><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Forward-Looking Statements Disclaimer</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as &#34;may,&#34; &#34;will,&#34; &#34;could,&#34; &#34;expects,&#34; &#34;plans,&#34; &#34;anticipates,&#34; and &#34;believes.&#34; These statements include, but are not limited to, statements regarding the Company's business and strategic plans, the timing of activities relating to the Company&#x2019;s GMP facility, the execution of potential future partnerships or transactions, and the timing of the Company's research and development programs, including the anticipated dates for enrolling patients in the Company&#x2019;s TCR-T clinical trial. Although Ziopharm&#x2019;s management team believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Ziopharm, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, among other things, changes in the Company&#x2019;s operating plans that may impact its cash expenditures, the uncertainties inherent in research and development, future clinical data and analysis, including whether any of Ziopharm&#x2019;s product candidates will advance further in the preclinical research or clinical trial process, including receiving clearance from the U.S. Food and Drug Administration or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final approval from the U.S. FDA or equivalent foreign regulatory agencies and for which indication; the strength and enforceability of Ziopharm&#x2019;s intellectual property rights; competition from other pharmaceutical and biotechnology companies as well as risk factors discussed or identified in the public filings with the Securities and Exchange Commission made by Ziopharm, including those risks and uncertainties listed in the most recent Form 10-Q and Form 10-K filed by Ziopharm with the Securities and Exchange Commission. We are providing this information as of the date of this press release, and Ziopharm does not undertake any obligation to update or revise the information contained in this press release whether as a result of new information, future events, or any other reason.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Investor Contact:</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">Ashley R. Robinson</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">LifeSci Advisors</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">617.430.7577</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(13,2,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Arial;">arr@lifesciadvisors.com</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>img55878624_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img55878624_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #& 90# 2(  A$! Q$!_\0
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M?7TKA0 .@ZG)]S7%5Q5M('O8/)KI3K_=_F>@ZG\6=5N/ETVSM[1?[TI,K?T
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M_P 5:3:G[KW2,V/1?G/_ *#BOHRNK!P3O(\?.Z[2C1775_H%%%%=Y\Z%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 455OM3L-,B\V^O+>UC_O32!!^M8;^/\ PZ24M;U[Z4?\
ML[.!YB?^^1C]:ESBMV:PH5)J\(M_(\:\3 CQ5J^?^?V8_P#CYK*KJM:T#7-:
MU^^O[+0]0$-Q*9(UFB\ML'UW$ <Y[TVW^'7BNXP3IT< />:X4?HN:\J5.3D[
M(^QIXFC"G'GFD[+JBIX*F6#QQH[OT,Q3\61@/U-?0=>/6GPHU])8ISJ=C;2Q
ML'0H'<JP.00>.]=&O@;Q'*/W_C>_!_Z9!@/_ $.NN@JE.+3B>-F3P^(J*:JI
M65MF_P D=]17G<GPQO9CF7QAJC_7/_Q50M\)"WWO$M\?J@/]:VYZG\OXG L/
MA>M;_P E9Z517F7_  J(C[OB2['UB_\ LJC?X6:M%S:>)Y ?]M'7^3TO:5/Y
M/Q*^K85[5O\ R5GJ->'?$U@WC>?'\,$2GZXS_6M2]\)>-='LY;D>)%,$*EG8
MWTL851U)SQ7 W-W<7]PUS=3233/C=)*Q+' P,D^PKGQ%5RCRM6/4RO!QIU'5
MA-25K:$52VBEKVW4=6E4#\2*BJ6TG2TO[6Y=-Z0S)*4SC?M8'&??&*XUN>Y*
M]G8^E+V W-C<6ZD!I8F0$]B017EFJ:;=W'B:XU>Y@N;:[CET^2.Q6.1TF\HG
MS0=B$.,-E2#U SC!%=!I_P 5=!N@!=QW5D^?XX]Z_FN?Y5T%GXN\/7SA(-8M
M#(>B-($;\FP:]>-6$MF?#U,)7I_%!_<6]&MI+32XXYAMD9GE921\I=R^WCTW
M8_"K]("" 0<@]#2UH<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !12,RH,LP4>I-49;ZXDE\JQM3+@
MX::0[(U_'JWX#\:3=BHQ<MB_6=/KNFP736IN1+<J,M! C2NOU5 2/QIEUI4V
MH*$O-0F$.?FBM?W(<>C');\B*MV.G66F6_D6-K#;1==D2!03ZG'4^]+WGL6E
M32U=WY?Y_P# ,6ZU7Q%=OY6CZ&L*][G4Y0B?@B$L?QVT]=#U6[@VZGXAN<GJ
MEA&MNH]@<%L?C7044N3NRO;V5H12_%_C?\#F[;P%X;M[C[2^G"ZN/^>MY(T[
M?^/DUOP6T%K'Y=O#'"@_AC0*/R%2T4U&*V1$ZM2I\<FSD_'FK:YHFE0W^D>0
M8D?;<^9'N*@\*PY'?@]>HKS63XC>*9,XU%4_W8(_ZJ:]JU738=7TFZT^X+"*
MXC,;,IY7/<>XZU\]ZWH]SH&L7&FW1#/$<JX&!(A^ZP^OZ$$=JX\5SQ?,GH>Y
ME"P]6#ISBG)>70N2^,O$LQRVMW8_W"%_D!70^"OB#/IUXUIKEU-/:3MN6YE<
MNT+>_?:?T/U-<%17+&K.+O<]BK@Z-2#@XI)]E8^G8I8YXEEBD62-QE70Y##U
M!%/KY\\.^+]6\,H\-C)&]LYW&"92R*?5<$$?AQ786WQA<#%WHF3_ 'H+CK^#
M ?SKOABH-:Z'SM;)\1"3]G[R^X]3IKNL:,[L%502S$X 'K7E]Q\825Q:Z&V?
M6>X 'Y*#7)^(O&VK^)(?LUR\<-F3DP0*0']-Q))/TZ>U$L532TU%1R?$3DN=
M<J_KL;OQ"\;Q:PIT;2V62Q#!I[@'B5@<A5]5!&2>YQCCKP%%%>?.;G+F9]+A
M\/##TU3AL%>@_##PY::K+?:A?VR7$$0^SQI(H9"QY;@]P-O_ 'T:XC3-/GU;
M4[;3[;_73N$!(R%'=C[ <FOH70M&MM T:WTVUR8XAR[=78\EC[DUOAJ7-+F>
MR.#-L5[*E[.+]Z7Y&#=?#/PO<,6CLY+8D?\ +"5E'_?)R/TKF]6^$&Y,Z5J0
M;_IE>)D'_@2C^E>IT5V2H4Y=#P:>8XFF])M^NOYGA\&C>/O#3#[+'?JB]!;R
MB>,_\ Y_]!JS9?%77K*Z\K4+>WN@G#QE##*/Z?\ CM>SUF:OX=TG78?+U&QB
MF/9\8=?HPY%9O#RC_#D=2S*E5?\ M%)/S6_]?,P]-^)7AR_B4SW+6,I'S)<J
M0%_X$,K^M=5;74%Y;I<6LT<T+C*R1L&5A[$5YQJ/PBMRC-I>IRQM_#'= .OT
MW#!_G7&&Q\4^"M0:2.*[M=C9,D(+V\@]_P"''U -+VU2'\2.A:P.$Q'^[U+/
ML_Z_S/?Z*\HTGXNSK(B:M81R1$X:>U)#+[[#G/X'\*]&TS7M+UF%9-/OH9P1
M]U6PP^JGD?B*WA6A/9GGXC!5\/\ ''3OT-&BBBM#E"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 88D,@D*@N.A/;Z4^BB@
MHHHH **** "BBB@ KG/%WA&U\4V*AB(;V')@GQTSU5O53_\ 7KHZ*4HJ2LRZ
M=2=*:G!V:/F:^L;O3+Z:ROH3#<PG#H3GZ$'N#U!J"OHK7/#FF>(;5H;^U1VV
MX28#$D?NK=1].E>4:S\,M<TQ6DL]FI0J"28ALD _W">?P)^E>;5PTH:K5'U6
M$S6E65IOEE^!QE%!RLC1NK)(O5'4JP^H/-%<QZ@444F<L$ )=NBJ,D_0#K0
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MC& 3V.?;(!'X_P#A-H.KZ)>7NDZ=%9:I!"TD8M5").0,['4<'., \$'\J?\
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MT:QL;73+""QLH4@M8$$<4:# 51T%%6** "BBB@ HHHH **** "BBB@ HHHH
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GA@> ?I5?P9X5A\&^'4T>"[DND21Y/,D4*3N.<8%%% '04444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ziop-20210927_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-27T16:03:40.3200+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Information, Former Legal or Registered Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ziop-20210927_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-27T16:03:40.3995+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ziop-20210927.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10091.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName" order="10150.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ziop-20210927.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2021-09-27T16:03:40.2876+00:00 -->
<!-- Copyright (c) 2021 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://ziopharm.com/20210927" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:ziop="http://ziopharm.com/20210927" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" namespace="http://xbrl.sec.gov/dei/2021"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ziop-20210927_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ziop-20210927_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>ziop-20210927_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ziop-20210927.xsd" xlink:type="simple"/>
    <context id="C_61372c8e-7fad-49b1-8780-ebcef0ff395c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
        </entity>
        <period>
            <startDate>2021-09-27</startDate>
            <endDate>2021-09-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_3b3dccd8-1d5f-4e09-8ebf-408b0d0293d0">0001107421</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_e55c8d0b-b596-4119-87e8-7710132cfec3">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_5c9b9364-31ec-4c74-8795-14da4f1a9395">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_eab4f9c9-36ca-4d85-a75d-5ecf50f8918c">2021-09-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_1e254f89-ca0b-4a3a-9a23-82e6f62c3dda">ZIOPHARM Oncology, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_770ad491-71ef-425c-900b-5315837a1f8b">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_0127a9b9-1da4-4edd-8e44-dcc013485407">001-33038</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_6c9baaf2-e098-402d-86aa-da28a07880bb">84-1475642</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_3ea4f041-be69-489f-aaa8-dd2b124ed89b">One First Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_d53c62f6-4de4-4c95-9089-de8a29362cda">Parris Building 34, Navy Yard Plaza</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_4486a0fa-6807-4acc-9f46-485e00ddfada">Boston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_6c856e64-39e9-42e5-a43b-94278055e3de">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_100dd3fa-f8d9-4bc5-9f67-a8302ca9185c">02129</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_4b65df2e-d69d-455e-ad89-c09d09b8e57c">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_68a1776e-f2e7-4677-8ad6-b4ea5eb20168">259-1970</dei:LocalPhoneNumber>
    <dei:EntityInformationFormerLegalOrRegisteredName
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_eb96a137-83d6-471a-9966-4c69f84566d7">Not Applicable</dei:EntityInformationFormerLegalOrRegisteredName>
    <dei:WrittenCommunications
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_a1636ccd-df32-4715-a8ca-74472a75aa35">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_9fc6b5fd-374b-4ee8-88ec-5a229b8c01ef">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_e7e18c2b-7958-44af-8efd-bd423c472a77">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_087f7cb2-9d8a-436b-b2e5-4ad31bdb5d40">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_e5d88138-610d-40cf-8e9e-88f12dd841eb">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_927e0269-7523-4c97-a554-fc39b00f8b05">ZIOP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_bd214ee7-92f0-4eaa-8baf-1c51fb07a24c">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_61372c8e-7fad-49b1-8780-ebcef0ff395c"
      id="F_0d1d83d7-19b9-4b92-b340-cf641fefe283">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140673255819752">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 27,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ZIOPHARM Oncology, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001107421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1475642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">One First Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Parris Building 34, Navy Yard Plaza<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Boston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02129<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">259-1970<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInformationFormerLegalOrRegisteredName', window );">Entity Information, Former Legal or Registered Name</a></td>
<td class="text">Not Applicable<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ZIOP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationFormerLegalOrRegisteredName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Former Legal or Registered Name of an entity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationFormerLegalOrRegisteredName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +: .U,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "V@#M3*[9CR>\    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+;
M2L0P$(9?17+?3MKU@*&;&\4K!<$%Q;N0S.X&FP/)2+MO;QMWNX@^@)>9^?/-
M-S"=CD*'A,\I1$QD,5^,KO=9Z+AF>Z(H ++>HU.YGA)^:FY#<HJF9]I!5/I#
M[1!:SJ_!(2FC2,$,K.)"9+(S6NB$BD(ZXHU>\/$S]05F-&"/#CUE:.H&F)PG
MQL/8=W &S##"Y/)W <U"+-4_L:4#[)@<LUU2PS#4PZKDIAT:>'MZ?"GK5M9G
M4E[C]"M;08>(:W::_+JZN]\\,-GRMJGX;=7>;%HN^)6X;-YGUQ]^9V$7C-W:
M?VQ\$I0=_+H+^0502P,$%     @ MH [4YE<G",0!@  G"<  !,   !X;"]T
M:&5M92]T:&5M93$N>&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M
M3A^%$5B-;'EDD81_OT<V$,N6#>V23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R
M>&#9+]O6N[<OWN!7,B0103 9IZ_PP JE3%ZU6FD PSA]R1,2P]R"BPA+>!3+
MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,!
M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K
MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2
MBW <!.!1NY["G?1LOZ1!";2C:=!DV/;:KI&FJHU33]/W?=_KFVB<"HU;3]-K
M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "V@#M3.JJBYT !   \ @
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MZ7FFUS>36TGHX-R#8._AE8P=S8\?=_<#4$L#!!0    ( +: .U,D'INBK0
M /@!   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2
MY0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D
M1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*<//Y#
M='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV-L%2XLM,EJ*H,AF**I9P6B#B
MR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^ 5!+ P04    " "V@#M399!Y
MDAD!  #/ P  $P   %M#;VYT96YT7U1Y<&5S72YX;6RMDTU.PS 0A:\295LE
M+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2%85-K'C>O,^>EZS>CQ&PZ)WU
MV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R
M;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$
M7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@
M9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!
M3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+
M 0(4 Q0    ( +: .U,'04UB@0   +$    0              "  0    !D
M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ MH [4RNV8\GO    *P(  !$
M             ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
MMH [4YE<G",0!@  G"<  !,              ( !S0$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    " "V@#M32PVY=9 $  "\$0  &
M    @($."   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
MMH [4Y^@&_"Q @  X@P   T              ( !U P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    " "V@#M3EXJ[',     3 @  "P              @ &P
M#P  7W)E;',O+G)E;'-02P$"% ,4    " "V@#M3.JJBYT !   \ @  #P
M            @ &9$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ MH [
M4R0>FZ*M    ^ $  !H              ( !!A(  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ MH [4V60>9(9 0  SP,  !,
M         ( !ZQ(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  -10

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ziop-20210927.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ziop-20210927.htm">ziop-20210927.htm</File>
    <File>ziop-20210927.xsd</File>
    <File>ziop-20210927_lab.xml</File>
    <File>ziop-20210927_pre.xml</File>
    <File>ziop-20210927ex99_1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ziop-20210927.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ziop-20210927.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ziop-20210927_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ziop-20210927_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ziop-20210927.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ziop",
   "nsuri": "http://ziopharm.com/20210927",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ziop-20210927.htm",
      "contextRef": "C_61372c8e-7fad-49b1-8780-ebcef0ff395c",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document And Entity Information",
     "role": "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ziop-20210927.htm",
      "contextRef": "C_61372c8e-7fad-49b1-8780-ebcef0ff395c",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://ziopharm.com/20210927/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000950170-21-001903-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-21-001903-xbrl.zip
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MC$1X[B\'@LY3DD6C(LY9(M(BBR<D [&9A1-5LZJ0^@",,EF[.J])SO;1 QR
M65@RJ;^%H)[3&ZR'*VX19O%G:]VO;V%'5_0U=YKQ/(51PVHC!=6Z77%O]>[.
M,[P>894M<)PN1OLK+[Z &F9ZU^P& :<\- U4PS9E;L"H8UF.P1R;,?/)QPW^
M+J,<* SW<11)E>B?K:[+^FD:^PS()0>B?=I4?_C>@PGLWZ4NF^SL54 #T,]#
MC8SGCE [+\#8M@R[XKJEH]/PQ+1=W2']=^?$,+4V%)SII_K4X:>1?G>C2=\+
M@ZYOAYR:CN532PB7NJX(J,T,P_/=0--%^%32OP#-&@ ^DJL/((U!),=;NO_\
M%&80(Z,*9*M$KUN,ZL8<W2^<$SBE>C!;RI);PE]PO1RANX'A4\>S76I9+*2N
M #[PN668@9+[3W:]SJ1 >8\'QZN39M' D*=A*.26 >[(6X6F@CG0W:D!=(M3
M8]??NQ\[E&6W#+%P"H3KA$[@&]3C+J.6V?6ICXEJ%N.F[G/?YI;VS PQR+)"
MR"U;?$&V, 6U\)*?^[!%57:5+;[-N;Y>8T(F]SPV<VIURFE0;0$CT]-^E:"J
M?$/ 0F\# LCFW>=6W7T^EFX_0R/6<B--.U5X.;QDS,)+FQ?E;@IWE?OD+_$:
MI_(4X6!(@IAEV;JP;P,P7082#=MNU?]CZWM-0OC+S!C><N 7XL!+R1 CU8TZ
MDQ&TL?MMDRRW[+=EOU?#?B7?G52G]BK])VI+'FQ*Z!/>S S/)^\=W&;K?J$E
M?YN[KFZZM*MKX#)K <:=/$%=-]0-SEU+%T_>SEZY(A/=\)7%U%"2QE  D.Y%
MG@8?6P2\%'+-XD*0OT-E32=CO 1QV,QS0AM$JB]7C[Q*^> 9CM",KD<=VS#Q
M% .',MNV:!B8GJ]IH>MK3UZ+K$RYTHAKJ'# >P"VC+]E_%?#^#XW=$L(AWI&
MJ%%+,$9=GX54#VP]]#6'&=:3\])KPZ". :N<OY68.]J5C=X6?G)X<73X*_DI
M3GV\IU[$(LC)!R8_BOR;) =6][Y]8=YNSC+$(.&XY""(/R&!RKB"Z7P$'T2H
M,VB7TJ&BC, D!"#B"A>T80HW^1!7+L:8(L4RPD4(D%-7CI39')J]YA:\V>5W
M)ME%&>7LJQTO1KBO,COJ2M =$/<8+RW!U,5R&<3PJ7'/F_56&L>ED5G]N>;;
M#4OA:L@%ELVFW>-/T.&]MI5\:NF4Z]PUN4-U/$7?\CV#^J:ET2#L6GHH0F&X
MYO.D<=>C_TD-OE^.O0FKIEL*O+_T##\C#UL@!=<*UV@ES70(HE.I/A"=2:I6
M&(M,J%( BBJ9%4IFD5IU'*NK"9%45%_Q!#N_B:!K)/\$!@A?I+B.,J@' IDE
M :8=L2# &T>P<):SA#/)LS*-E7]J>=/<9=/ES7D)VWZ.O5O+]/C<-RGI3TXH
M-ZJ )T\+7,==I*G-2A_?7)\%YSR<1CG'[$J4G@=E(:CN'HMOV"3;WR&=IYA]
M[A/!\\V2ZQ]C= ]R,2)@Z-JDGV8YV&-9E@:87L]+*7)\&^4H0HZB;)QF(#F
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M/FWD0O=!QT_YY.UW!YUA/HK?_C]02P,$%     @ MH [4^7"-C(; P  J@D
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M#?_NCI-[LY/MP'4:-T(#_I4J_UV9[UD^CS2U0]^3--$ +J*'<W/OON\-91+
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MHF<3A9^U]?VA=ZG"(@8>0)!,>LJ6"7\'Q+0+"KD[6YJU0MJ)ERCP:Q/Q; 5
M$^KZ)9G*9!KQQ_>.P'AOCU0L/3].+3%O!*QE'+9;YZ;3QMD+] QVF3?)H;/;
M?G8Z'5S"-NY#'1% WN1L-Y^=3.I<3R"I0/\*],:8PRH?5QJ](5H\PBII/CN9
M5?2U@P"C3*T?&&7@Y# KQOYG--U7T'1+IJF=_E$.Q9R?(KF%+)?BD\ CB_U#
MHX*X/0(NE^@ ]W]XE$]2/%-]Q)Z@N@\OB6P'PU9ZK(<'TN(O6!:RW,>51.\V
M!#G!*^J?4LSC:4>$D<>+2>:C2Z+:I0P>9N$(9"&_+4A)I/ "+&0D9'(525RL
M(V:XDLNCT7.\5VG4-]>K+KZ O(.)QQYE'R94Q2 A>/#"8QI>U+TD,:M1I<?C
MHZ3W8"61&WJ+7H#Q3<=TE?><<.,B_-GIZKR,/4T%+PZT \C923U)C(X0KS\^
MZ#M03ZD9R*&^X<O'\3B7Y,DN99-^%=U2B0[ GTGT.<<=#75RE4/O %(:J=N%
M/_7X! IB.A=V?G*"49_&> S>X\8MJ<?RJ!V"SDYL*#U=;1HLPY'(X[3;?G8Z
M?^/28"*N/7O&UQN9RJ&5C]NAMYWOM^4N54_ZJ5%\W:D^'!9\U@@K\B3:,_TI
M94':>RQ%F)>WIZ.)O"R:"(FQVC(<VW9L7?.+,&_4/MDR, ^9*20C(DU[WP'^
M3Y)V,_6-(J=>644%Z7ZV6&[EI:U*!9DBN[**CM0;,GF--R?/W9'GO EYV_6-
M;!]Y(ZZY5QG)]%5W,SE>4,D45O=L*ZC"9)'WL>+2"BHXF<!/%1>X7??)5'VN
MN*H3A:-,Z&7EA;ZLS)1M-E5WV/U:5+:6U;U0GRAD91)_KZS$P^)7YI+5/21.
M5\\RE=6]8Q\KMV7ZJNN;AU6ZC2JWNG>S_#+?1EF]NE&75R/,_+"Z1_I>B3%S
MPNJF0 5ERFRU7G;3O+(.E&&2_^/Z8MV@_^A_-;O^"5!+ P04    " "V@#M3
MS[0J1> ,   $1@  %P   'II;W M,C R,3 Y,C=E>#DY7S$N:'1M[5QM<]LV
M$OY^OP*33GO)C"2_U7$LN9ESG+3U)8USMCN]Z9<;D 1%Q"3  *!DY=??LP"H
M%]MRG2:NU5:3F82B2&"Q^^S[*@>%J\KG_V 'A> 9_F4'3KI2/'_UW^[^?F_K
M8"-\Q ,;\8F#1&<3_V3-K)N4XKM'3ERZKE294*Z_V=O\>I!KY;I6?A3]+7RN
MW:#B9BA5U^FZ'VZ44HEN(>2P</VMWDYX(^>5+"?]<UD)R]Z*,3O5%5?MRXEV
M3E?Q?;\E+^50]4N1N\&CYP>T1$O1N)!.=&W-4]&OC>B.#:^O4W7;IH^>?_/5
MUM/-P<$&/?7\8*->I3,;6N3JH1.>7@R-;E36376I3=\,$_YXL^/_/!E<N[?U
M9+"<3^- 9Z++[';&'1K)2Y#RZK*0B70LP&85F=8"159#9DWZW2-<[.X^VWOV
M=/O;_VWVWM?#1XR7[L;[+:YDYHK^]N9V?3F(1.WOXWJ&EL\Y\=:S+WWD%/L*
M\Q! V5X*E%^EK@MN*G:B:*?AA!TJ!6)2'.S,&>[$4*;L5&1-ZJ163"KVBS87
MN3:I8%QE[-6E$\K&KXZX+=AIH\9\<@5UF1RU!\ZDK4L^Z>>EN+P#P]\WULE\
M N: >Q!<Y*)G:1=\J&P_X5;0:S<*H,*-@)3-WO:N5 \C$:5-!8;/R63KFDS.
M)A4$-VCY(Y5G15+J].).+U[E%#&X:QTW-S"!=.0RWTSVIC;U!@D%"E:%/0&R
MX1&BI"\=I)B"O).1,&QW\VMFYG%:"V.U4J*<0A%'C'_?$9([:T2N$?E[$'FD
MK9NAT3)Q68O4B8PYC6OP E>%8"G92^/M)1"+[^AF+@U>+GB9,YTSN+>=-8#7
M /Z# 7P^!6+-G<31R:)*9]GYT6GWG+V1B>%FPMX5P D[WC@^9BD.)E->,D>+
M,KD(^D2P3%M<8YFM'P'J[26@7I5@[:9$YF%C^A<G9^<G;WW0]>/)SW3=86>B
MAKHF<'_;>QVR%=-H_X^'UW+*6;?+/I^N[=W=3Z',RS(3J480"QO<QR[">.6[
M$\W7 N-59&R'':NTQQ[#\&QO;J6#ENCP.1LP;;Q+:;\_TE7-U:3]^@E[_);;
MC'_HLU^/3]X]Z7RFE+9V.MOW<$JG,_A''O.2C'%X5NL,?&MCI!HRH7A2TH5W
MJ>&(9'-X-N)XH35;K#9Z:'C58X<U+B]EA>RFG+"GFZS65@9'7?"1@+$2BL']
MP<3CD:S'R!I&WD6K9L-F!5=#6)6Q+,O?X==[7R0UC]G=RMB^>T+!:S&"[SCK
ML1<:!,'TF5Z''152Y,A!1=HX"<F=Y+E,A>DPRV76F>+^%^2JD+E()>3IA5&1
M*,FK&YDT0?1T6T+&WF6)JB[U1(!K%<\$H6EJ$,@ CSW0*NGH&]O4M38N(A#^
M<,3+!FN )Z7@PP:+9 &IKH!;1%:M MQZ[!<"6RG%B+8 R@/!^P,+MK?)-VR8
M] GVF%NF!#)S2ZX7&Z=&T'FX@IX/N9(?O:5CK6Z0JH!6A"MYCFOD[" UI??]
M_5RG#7EDO$%''VIX;0!S*)0@DPERIRX]XXZ3Y]:-(2VJ0 ^^7@P%IMIUS'A%
MK,UE%N,&6IXGLI1N0CO0*@7D#]U#N$'Q(K1&X"4?'),HA7\FLF#2:^W57U)=
M[L<SM,@GR_5"<Y-10)8W)7C>PA68@S""6G%ON/!(RFN* 1DO$2-/X>3%X!_R
MD"/A>_0P[J9ZT9DZ'=(]]F].//RQ@8'LS"GH4<$E3J%H:]?2UF-7'1A12QAK
M2FY*KZB45Q ='J^)(!(X@WIE,R2VIM\KJ'1%.!$/!8'@1,)I$;1"JRHH?5R2
M*)DIW"BH&RU#&PAC"PFL7<#(DP**+"H3831O2-'^V@B])X,^[U1Y:?6<AW?W
MF'W<Z(JW&<^1MOJ7##9,"56-@I1ASQ$,9 +)&VF'MY@)>74 XT-#YA>/  E4
M,(4V$)'>K0!VY&2:G'M3;!:#"!F>DJKQ;D%CO1%BFO:8>JSF7O:FF-?!@DKL
M0[$-['A)=EI,6803>JU065B>W%,\/Z(:^DI2:J[ GEO6UK4( 3-Q<2FW9E[O
M!ED%0M;!S>_4!3+4,]<<'"*)*?KI'%&%'M.-"S&9LUKDOVU_>=D]LH6.[RGY
M>K"L:'1SK^>64L@7*1RME%SN6#=:^N+*U8WN";=';3B G$PG.#0[A<'D)BW8
M-[RJ!^PE0MM2UQ79A84@U1N=4ER).(_?><^JH,PP];!T )'PWQ3:V5K#IC;.
M+V!_NRBZ1OP:\5\<\2<S_R@__I93#?B>RP\%A;/$EJ$(D<H:QFL8/P2,?UB6
MY:]BF3-6'D+P'R)E.6R#5*]&:RU::]%#A#]S.1Q5]6IN*-"AW*LAG?*1CB]%
M^'I6@:\+75)%(53FA/%Y&;<KJ79(;&L$6I+<F'5BS$UFR9_%&M%?NH'W"8"Y
M>P?O,-'-K& V[2R%+LYJC^FME-K-5PGYU'_%L$I'KG;;)#H594F9,W:<M#7"
M#LM"8N*KAUW_B!&IJ!VRC\=P-$_B&U02(9ON<W$JS2BMNB-IX'A6L%<6'EGL
MY)^50OACOA"\<9_9QKPG@?H4,)C07!@&D^^0!H96"S$=QO1#0VTUE>+K-A6,
M9< .A#H2(>B&X:4R25-ITS6B],7=:<9(]2RJF7B$3!S53+"MI:9(03;X]>GA
MF=_R_-WNSF*]CBK&TS@I-%7:N@MU>7@2N\RV+3P+]K8-4(X"U<<*/M$U+HQ-
MTN(_*PFZ;>R*G(M+;/+32W9(C6JK5?OBD9^HZ;'O 4V<2^ 8Q!R_? >\$E0$
MI9JU^],UV<?C<>]C5.8>A+>2X/P36>9[F[0O3+M%#1O;38S@%UU?,N_S<LPG
M%B_^77FS#GB6J@Y,%D6-W3=:7Y!]/H,E%E0+M.REM&G)<4+SYU&O!S=%Y]30
MQ"K6(EH)AI]2+"X5]0P"K\O(:SOCM6]WYN#-M 'VSL@1]8[.1-J8T/AY(]ND
MFIT*[WT/4T>.:6M_?[=#:W"LEM$XS/>W;&7$_$=7<.?O*?AK$(_PRKM0JI/9
M3O#OBEE=^9D901TVZNXR/SH@<QF:;3 SU<Q-?_/5SK>0WJ3C+\)'&L"9_YSJ
MILSF;\2IG?E;B#+4P@V.+5-9@_CV-M'GK^*0ANV%^^=^S&/NG%*E99.)#DN:
MV7EI@"@TX#KSSQHQ!//:>:488?P3869C(:(XG#&++P*9_EE'$TE#D@DUM4=!
M;C[,B5W$N05GDR0__/2.^.W'+\(ZL:>D?1<>D13QFH3B>]D,2:Q3H>EM_0 9
MA66ABQY%MDC+XBE,6_^G![.YZG^<#\$2@5DM V9<SZ@")3R2F5 &<14]$[N*
MMH7NM?/%YO]" [C'#DM7Z&98L,69.'H!V@\GYHGR8R>M< -: X,(+3&B,R(O
M0R>9H$H@O$W5##6$.<(WJOYV8K5*F_!-RCW;?8<;6UU=9RZP:R=W%O2J2=Z#
M$!+TB!NI&] F[44 ##7.#5D" D4GS#=!.# _) N\G4F:C6I*_SYL2":Q%+T9
MVB\T&9*(B6XGV&!6( %:8CK@$8CVJA4ZX03#AE/F9+&NO2IRWZBF;1'$TJP=
M"0:[Y$976$I;SV<R9IZU'<*:K.J2E%[[.:/W@>U)A.W=V=6+&KJ$/3-UY4@7
M &+*]6A:1 W!NG:H;QG>8H><H$FJ&;A2T:2?'QX+(P T $@H4IDDI8H*?)4*
M;!N'&Y:I3:?5RL4J+3T%%)<3*Q<4:EP(?Y8H_>O8!U?I1PED9S,9U,T/+[:S
MDGEC_ +Q\#0SUVX\)1'"N3)N@55IK&R>$LJFY2C4E_%:6#Q('IE/[XR\B X#
M:B]-,V2'&>R)]&;/&R:8@ \-G!3-AY'DX2R)2S01!'6:,&BP2N,P!, :#K5
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MA:15X?IJL!:\YY2"3 OK P6?-3M^(8+>@J$Q$ .VFSJL9[ (DOPPO3J_<0P
M6W9<"Q"G"F##X#1Y %!'+?:%0D*T,S ]BD(S'8V(?S=XM+_]1,_=$Y_CZ/89
M=0B@2%?G<M9)SBU5<EN4,,NG/9PA06:CU9IY=V;>&YF+LU3"G<)8P'RO67=G
MUCW=VNM]N[/9V]O=VUNS[<YLX\;\JP3J;"IY!-U\*7?U.?C 1=.#C?!_N!QL
M^/_]Y?]02P$"% ,4    " "V@#M3SVG?NNP6  #ES0  $0
M@ $     >FEO<"TR,#(Q,#DR-RYH=&U02P$"% ,4    " "V@#M3Y<(V,AL#
M  "J"0  $0              @ $;%P  >FEO<"TR,#(Q,#DR-RYX<V102P$"
M% ,4    " "V@#M3"J[EN^(%  ##-@  %0              @ %E&@  >FEO
M<"TR,#(Q,#DR-U]L86(N>&UL4$L! A0#%     @ MH [4P5/8K6V!   *2@
M !4              ( !>B   'II;W M,C R,3 Y,C=?<')E+GAM;%!+ 0(4
M Q0    ( +: .U//M"I%X P   1&   7              "  6,E  !Z:6]P
I+3(P,C$P.3(W97@Y.5\Q+FAT;5!+!08     !0 % $D!  !X,@     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
